First-line ipilimumab plus nivolumab in advanced merkel cell carcinoma: a meta-analysis of prospective trials and real-world validation cohort
一线伊匹木单抗联合纳武利尤单抗治疗晚期默克尔细胞癌：前瞻性试验和真实世界验证队列的荟萃分析
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-026-04313-2
Ramadoss, Tanya; Palacios, Christian; Nichols, Matthew; Eroglu, Zeynep; Markowitz, Joseph; Karapetyan, Lilit; Tarhini, Ahmad A; Wuthrick, Evan J; Sondak, Vernon K; Tsai, Kenneth Y; Khushalani, Nikhil I; Brohl, Andrew S
